Croissy-Beaubourg and Montpellier, October 16, 2017, 8:00am CET – THERADIAG (ISIN: FR0004197747, ticker: ALTER, eligible for PEA-PME equity savings plans in France), a company specializing in in vitro diagnostics and theranostics, today announces that its…
Excellent momentum for theranostics sales: +43%Second-quarter revenue growth: +12% Croissy-Beaubourg and Montpellier, July 25, 2017, 6 pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER, PEA-PME eligible), a company specializing in in vitro diagnostics and theranostics,…
Croissy-Beaubourg and Montpellier, France, 14 June 2017 – 8.00 am CEST – THERADIAG (ISIN: FR0004197747, ticker: ALTER, eligible for PEA-PME equity savings plans in France), a company specialising in in vitro diagnostics and theranostics, is…